Inventor · disambiguated record
Luca Fadini
Also filed as: FADINI LUCA
9 granted patents·2 pending applications·28 citations·filing 2012–2022
84Inventor score
Top patents by PatentIndex Score
11 records- 0194US8426450B1Substituted 4-phenyl pyridines having anti-emetic effectFADINI LUCA·Filed 2012·Granted Apr 23, 2013·22 cites·3 claims
- 0289US10208073B2Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2018·Granted Feb 19, 2019·2 cites·13 claims
- 0385US9403772B24-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2012·Granted Aug 2, 2016·4 cites·14 claims
- 0479US12071421B2Process for the synthesis of substituted chloromethyl dialkylphosphatesHELSINN HEALTHCARE SA·Filed 2022·Granted Aug 27, 2024·0 cites·3 claims
- 0575US11312698B2Fosnetupitant chloride hydrochloride having improved stabilityHELSINN HEALTHCARE SA·Filed 2020·Granted Apr 26, 2022·0 cites·12 claims
- 0671US10717721B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2018·Granted Jul 21, 2020·0 cites·2 claims
- 0767US9908907B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 0864US8895586B2Methods of treating emesisFADINI LUCA·Filed 2013·Granted Nov 25, 2014·0 cites·21 claims
- 0949US10005803B2Crystalline forms of fosnetupitantHELSINN HEALTHCARE SA·Filed 2016·Granted Jun 26, 2018·0 cites·23 claims
- 1049US2018291049A1Crystalline Forms of FosnetupitantHELSINN HEALTHCARE SA·Filed 2018·Application pending·0 cites
- 1149US2022169617A1Continuous process for producing benzimidazole derivativesHELSINN HEALTHCARE SA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →